<?xml version="1.0" encoding="UTF-8"?>
<collection>
<dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:invenio="http://invenio-software.org/elements/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:identifier>doi:10.3390/nu15183983</dc:identifier><dc:language>eng</dc:language><dc:creator>García-Mateo, Sandra</dc:creator><dc:creator>Martínez-Domínguez, Samuel J.</dc:creator><dc:creator>Gargallo-Puyuelo, Carla Jerusalén</dc:creator><dc:creator>Arroyo Villarino, María Teresa</dc:creator><dc:creator>Laredo De La Torre, Viviana</dc:creator><dc:creator>Gallego, Beatriz</dc:creator><dc:creator>Alfambra, Erika</dc:creator><dc:creator>Gomollón, Fernando</dc:creator><dc:title>Lifestyle can exert a significant impact on the development of metabolic complications and quality life in patients with inflammatory bowel disease</dc:title><dc:identifier>ART-2023-136453</dc:identifier><dc:description>Inflammatory bowel diseases (IBDs) are associated with an increased risk of metabolic comorbidities. There is a lack of data regarding the relationship between lifestyle and metabolic diseases in IBD patients. A cross-sectional study on consecutive IBD outpatients was conducted. Adherence to the Mediterranean diet (MD) was assessed using a 14-item questionnaire from the PREDIMED study, and physical activity was evaluated using the GODIN-Leisure score. Body composition was studied based on body mass index and waist–hip ratio (WHR), while quality of life was assessed using a nine-item short questionnaire. Among the 688 evaluated IBD patients, 66% were overweight or obese, 72.7% did not lead an active lifestyle and 70.1% did not adhere to the MD. Metabolic syndrome was associated with age (OR = 1.07, p = 0.019), overweight/obesity (OR = 12.987, p &amp;lt; 0.001) and the inflammatory behavior of Crohn’s disease (OR = 6.172, p = 0.001). Type 2 diabetes mellitus or prediabetes was associated with age (OR = 1.063 p = 0.016), overweight/obesity (OR = 3.861, p &amp;lt; 0.001) and the inflammatory behavior of Crohn’s disease (OR = 4.716, p = 0.001). Overweight /obesity (OR = 5.494, p &amp;lt; 0.001), a high WHR (OR = 2.564, p = 0.005) and a non-active lifestyle (OR = 2.202, p = 0.0003) were associated with metabolic dysfunction-associated steatotic liver disease. Lifestyle, body composition and not solely systemic inflammation might exert a significant influence on the emergence of metabolic comorbidities such as MASLD, type 2 diabetes mellitus and metabolic syndrome in patients with IBD.</dc:description><dc:date>2023</dc:date><dc:source>http://zaguan.unizar.es/record/130144</dc:source><dc:doi>10.3390/nu15183983</dc:doi><dc:identifier>http://zaguan.unizar.es/record/130144</dc:identifier><dc:identifier>oai:zaguan.unizar.es:130144</dc:identifier><dc:identifier.citation>Nutrients 15, 18 (2023), 3983 [14 pp.]</dc:identifier.citation><dc:rights>by</dc:rights><dc:rights>http://creativecommons.org/licenses/by/3.0/es/</dc:rights><dc:rights>info:eu-repo/semantics/openAccess</dc:rights></dc:dc>

</collection>